SCHEMBL7445908

SCHEMBL7445908

BrCc1ccc(-c2ccsc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.56
CYP11B1 P15538 1/20 0.56
CYP11B2 P19099 1/20 0.56
CYP2A6 P11509 6/20 0.52
CYP2B6 P20813 3/20 0.52
CYP2E1 P05181 2/20 0.52
KCNH2 Q12809 1/20 0.44
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
PRMT6 Q96LA8 1/20 0.40
LTA4H P09960 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GRIA4 P48058 2/20 0.38
TRPA1 O75762 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
ACMSD Q8TDX5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27989815 0.81 CYP2A6 (0.74) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL8343615 0.78 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL5023933 0.78 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL112385 0.78 HRH3 (0.61) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL8309627 0.78 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL5828167 0.78 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL4056073 0.78 CYP17A1 (0.56) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6
SCHEMBL679626 0.78 TSHR (0.56) TRPA1ALDH1A1TSHR
SCHEMBL9609757 0.78 TSHR (0.56) TRPA1ALDH1A1TSHR
SCHEMBL4171349 0.76 PRMT6 (0.63) CYP17A1CYP11B1CYP11B2CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977075-A N-aroylamino acid amides as endothelin inhibitors NOVARTIS AG (CH) 1999-11-02 US disclosed
US-5780498-A PEPTIDE DERIVATIVES FOR CARDIOVASCULAR AND BRAIN DISORDERS CIBA-GEIGY JAPAN LIMITED (JP) 1998-07-14 US disclosed
EP-0821670-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS Novartis AG (CH) 1998-02-04 EP disclosed
US-5703106-A TREATING VARIOUS CARDIOVASCULAR, UROGENITAL, BRAIN DISORDERS JAPAT LTD. (CH) 1997-12-30 US disclosed
EP-0753004-A1 ANTAGONISTS OF ENDOTHELIN RECEPTORS Japat Ltd (CH) 1997-01-15 EP disclosed
WO-1996033170-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS NOVARITS AG (CH) 1996-10-24 WO disclosed
EP-0728145-A1 ENDOTHELIN RECEPTOR ANTAGONISTS Ciba-Geigy Japan Limited (JP) 1996-08-28 EP disclosed
EP-0682654-A4 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE. MERCK & CO INC (US) 1996-01-17 EP disclosed
EP-0682654-A1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO. INC. (US) 1995-11-22 EP disclosed
WO-1995026360-A1 ANTAGONISTS OF ENDOTHELIN RECEPTORS JAPAT LTD. (CH) 1995-10-05 WO disclosed
WO-1995012611-A1 ENDOTHELIN RECEPTOR ANTAGONISTS JAPAT LTD. (CH) 1995-05-11 WO disclosed
WO-1994018169-A1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1994-08-18 WO disclosed
US-5284841-A Benzo-fused lactams promote release of growth hormone MERCK & CO., INC. (US) 1994-02-08 US disclosed